REYKJAVIK, Iceland , June 16, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the pricing of its previously announced underwritten public offering (the “Offering”) of 22,666,667 of its ordinary shares at an offering…
Bank of Spain-regulated card issuer combines human-led and agentic AI pentesting to surface business logic risk and meet regulatory traceability requirements Bank of Spain-regulated card issuer combines human-led and agentic AI pentesting to surface business logic risk and meet regulatory traceability requirements
Þann 12. mars 2026 var tilkynnt um undirritun Sýnar hf. (Sýn) og Ása hf. (Ása) á skilmálaskjali um kaup Ása á vef- og útvarpsmiðlum Sýnar. Frestur samkvæmt skilmálaskjalinu til að ljúka gerð endanlegs kaupsamnings og annarrar nauðsynlegrar skjalagerðar er nú liðinn án þess að kaupsamningur hafi verið undirritaður. Samkomulag um einkarétt Ása til samningaviðræðna er…
